EUVIMEDOpdag EUVIMED
BeobachtungsstudieQuerschnittstudie

LIpid Response to Statins ± Ezetimibe In Mumbai (LIRIM): A Cross-sectional Observational Study

V T Shah

Journal of The Association of Physicians of India · 2024

DOI: 10.59556/japi.72.0622 ↗

At a glance

Beobachtungsstudie in Journal of The Association of Physicians of India, 2024. Written by V T Shah. Institution: Director of Cardiology, Surana Sethia Hospital, Mumbai, Maharashtra, India, Corresponding Author. Major MEDLINE topics: Ezetimibe, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cholesterol, LDL, Anticholesteremic Agents. Cited 1 times so far (Crossref); 42 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

BACKGROUND: India has the highest burden of cardiovascular disease (CVD) among developing nations. Data from international studies show significant underimplementation of recommended aggressive lipid-lowering strategies for achieving low-density lipoprotein cholesterol (LDL-C) goals, especially after percutaneous coronary intervention (PCI), a pattern also observed in India. Moreover, ethnic variation in response to statin therapy has prompted clinicians to adopt lower doses of statin therapy in Asians to achieve comparable LDL-C lowering. OBJECTIVE: To document the dose of statin ± ezetimibe required to achieve the European Society of Cardiology (ESC) goals of LDL-C 55 mg/dL on current therapy were switched to R 40 mg ± E 10 mg daily. The final data set (n = 340) included those who achieved LDL-C goals at the initial visit and those at follow-up. The primary and secondary outcomes assessed the impact of R 40 mg ± E 10 mg (R40 ± E10) on LDL-C (

Subjects

MeSH terms (MEDLINE)

EzetimibeHydroxymethylglutaryl-CoA Reductase InhibitorsCholesterol, LDLAnticholesteremic AgentsHumansCross-Sectional StudiesMaleIndiaRetrospective StudiesMiddle AgedFemaleAtorvastatinDrug Therapy, CombinationAgedRosuvastatin Calcium

Substances

EzetimibeHydroxymethylglutaryl-CoA Reductase InhibitorsCholesterol, LDLAnticholesteremic AgentsAtorvastatinRosuvastatin Calcium

Authors and institutions

  • Director of Cardiology, Surana Sethia Hospital, Mumbai, Maharashtra, India, Corresponding Author.

Cite

APA

Shah, V. T. (2024). LIpid Response to Statins ± Ezetimibe In Mumbai (LIRIM): A Cross-sectional Observational Study. Journal of The Association of Physicians of India. https://doi.org/10.59556/japi.72.0622

Vancouver

Shah VT. LIpid Response to Statins ± Ezetimibe In Mumbai (LIRIM): A Cross-sectional Observational Study. Journal of The Association of Physicians of India. 2024. doi:10.59556/japi.72.0622

BibTeX
@article{Shah2024,
  author = {Shah, V T},
  title = {LIpid Response to Statins ± Ezetimibe In Mumbai (LIRIM): A Cross-sectional Observational Study},
  journal = {Journal of The Association of Physicians of India},
  year = {2024},
  doi = {10.59556/japi.72.0622}
}
Start for free →